TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.00$ +0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Evolus Inc (EOLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 297 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 35 57 100 149 202 266 297
0.4 0.3 0.2 0.0 8.0 18 44 59 62 84 104
-0.4 -0.3 -0.2 0.0 27 38 56 90 141 182 193
21 13 6.7 6.5 4.0 1.7 2.1 6.7 15 9.2 9.6
9.9 7.0 4.8 29 29 98 118 130 157 189 221
31 20 12 36 126 191 101 155 190 217 230
-31 -20 -12 -46 -99 -153 -44 -65 -49 -34 -38
0.0 0.0 0.0 0.9 8.0 11 1.4 9.1 14 19 20
-31 -20 -12 -47 -105 -163 -47 -74 -62 -50 -51
0.1 0.1 -7.3 0.1 -15 0.1 0.0 0.1 0.2 0.7 0.7
-31 -20 -4.5 -47 -90 -163 -47 -74 -62 -50 -52
-31 -20 -12 -46 -92 -145 -39 -54 -42 -25 -23

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?